Last week, Eli Lilly said it would cut the monthly price of its starter dose of Zepbound to $349. The U.S. drugmaker also is ...

Novo Nordisk A/S (NVO) has slashed prices for its blockbuster weight-loss drug Wegovy as competition in the obesity drug market heats up, with ...

The discounted price is aimed at uninsured patients and those whose insurance doesn't cover weight-loss medications like Wegovy. The move follows a similar price reduction by competitor Eli Lilly ...

Novo Nordisk said Wednesday it will sell Wegovy for $499 a month in cash to patients who can’t get the blockbuster weight-loss drug through insurance, a bid to reach consumers who can’t afford the $1, ...

Eli Lilly began offering vials of the two lowest ... Danish drugmaker Novo Nordisk will also offer home delivery of Wegovy, which can cost patients more than $1,000 a month if they do not ...

Strong demand for both Wegovy and Eli Lilly’s Zepbound led to shortages of those products. Compounding pharmacies pounced, taking market share with their custom-made, lower-cost versions of GLP ...

Eli Lilly began offering vials of the two lowest ... Novo said its discounted Wegovy would be available in pens of all dosage strengths to uninsured patients or eligible patients with commercial ...

Patients either need a prescription from their doctor or can get one online through a Lilly partner. Now, the company is adding the 7.5 mg and 10 mg vials. And on Wednesday the maker of Wegovy ...

Last week, Eli Lilly (LLY) said it would cut the monthly ... the drugs during the shortage will have to wind down production. Wegovy and Zepbound are part of a GLP-1 class of treatments that ...